Investor Relations

„Stefan Eschbach GmbH, is investing into innovative MedTech-Companies (“

Sebastian Burian: “I am pleased to support LBC in realizing their vision of autologous blood management for tumor patients and to pave the way from product developmemt to market launch with this financing round.”

Andreas Billand: “PermaDoc is excited to support this important project which aims to improve the life of cancer patients.”

Dr. Klaus Hilleke-Daniel: “Improving the quality of life of patients is a guiding principle of our investment descisions. We are proud to support Lindis Blood Care in bringing their exciting new product to market.”